drugset / Trial / NCT01035411
AZD9668 Relative Bioavailability
RandomizedSingle-groupOpen-label
Summary
This clinical study will aid future formulation development and optimisation of AZD9668 tablets by evaluating possible effects of minor changes to the formulation and process on the rate and extent of absorption.
Timeline
- Start
- 2009-11
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alvelestat | Small molecule | 60 mg | Oral |